Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

May 13, 2021

SELL
$132.81 - $182.18 $16.4 Million - $22.6 Million
-123,802 Closed
0 $0
Q4 2020

Feb 12, 2021

SELL
$138.17 - $184.34 $209,327 - $279,275
-1,515 Reduced 1.21%
123,802 $21.4 Million
Q3 2020

Nov 06, 2020

BUY
$114.09 - $145.51 $4.68 Million - $5.97 Million
41,044 Added 48.7%
125,317 $17.5 Million
Q2 2020

Aug 03, 2020

BUY
$89.45 - $129.85 $3.39 Million - $4.91 Million
37,848 Added 81.53%
84,273 $10.1 Million
Q1 2020

May 14, 2020

BUY
$70.23 - $144.31 $3.26 Million - $6.7 Million
46,425 New
46,425 $4.64 Million

Others Institutions Holding NVRO

About NEVRO CORP


  • Ticker NVRO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 35,387,800
  • Market Cap $116M
  • Description
  • Nevro Corp., a medical device company, provides products for patients suffering from chronic pain in the United States and internationally. The company develops and commercializes the Senza spinal cord stimulation system, an evidence-based neuromodulation platform for the treatment of chronic pain, as well as Senza II and Senza Omnia systems. It...
More about NVRO
Track This Portfolio

Track Granite Investment Partners, LLC Portfolio

Follow Granite Investment Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Granite Investment Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Granite Investment Partners, LLC with notifications on news.